We would like to invite you to attend our Board of Directors Forum focused on the current regulatory landscape and the role of the public board, particularly the audit committee, in helping drive audit quality. This presentation hosted by BDO will provide a small group format for Board Members to discuss the topic in further detail.
We have assembled an impressive panel consisting of a key note presentation by a Public Company Accounting Oversight Board (PCAOB) board member, who will then be joined in panel with several industry leaders in a question and answer session. We hope you will join your fellow public company directors to engage with our panelists and each other.
Jay Hanson, Board Member of the PCAOB
Jay D. Hanson was appointed to be a Board Member of the Public Company Accounting Oversight Board by the Securities and Exchange Commission in January 2011, and reappointed for a second term, ending in October 2018. Prior to joining the Board, Mr. Hanson spent nearly 32 years at McGladrey & Pullen, LLP. At the time of his appointment to the PCAOB, Mr. Hanson was the National Director of Accounting, overseeing the firm's accounting guidance and training practices, as well as leader of the firm's Accounting Standards Group.
Mr. Hanson served as a member of the Emerging Issues Task Force of the Financial Accounting Standards Board (FASB) from 2006 to 2011. He also was a member of the Financial Reporting Executive Committee of the American Institute of Certified Public Accountants (AICPA) from 2005 to 2011, serving as Chairman from 2008-2011.
Chris Lindop, Board Member and CFO
Chris Lindop joined Haemonetics Corporation (NYSE: HAE), a global leader in blood processing technology, in 2007 as Chief Financial Officer. Shortly thereafter he assumed added responsibility for business development and strategy. During his tenure, the Company has completed 11 acquisitions and expanded its product offering to include software and consulting services. From September 2003 to December 2006, Mr. Lindop served as Chief Financial Officer of Inverness Medical Innovations, Inc. (now known as Alere – NYSE: ALR), a global developer, manufacturer and marketer of advanced consumer and professional medical diagnostic products. From June 2002 to September 2003, he served as an audit partner with the Boston office of Ernst & Young LLP. From 1991 to 2002, he served as an audit partner with the Boston office of Arthur Andersen LLP.
Mr. Lindop has served as a Director of Parexel International Corporation (NASDAQ: PRXL), a multinational biopharmaceutical contract research organization, since 2006, chairing the audit and finance committee and as a member of the nominating and governance committee. He has previously served as an Overseer of the Boston Symphony Orchestra and as a Trustee of the Concord (MA) Museum. Mr. Lindop is a native of Scotland and a graduate of the University of Strathclyde.
John McGillicuddy, Board Member
John McGillicuddy currently serves as a Director of Cabot Corporation (NYSE: CBT), a leading global specialty chemicals and performance materials company, as the audit committee chair as well as on the executive, governance, and nominating committees. Mr. McGillicuddy is also Chairman of the Board of Directors of Watts Water Technologies, Inc. (NYSE: WTS), a manufacturer of water safety and flow control products, and a Director of Brooks Automation, Inc. (NASDAQ: BRKS), a worldwide provider of automation, vacuum and instrumentation solutions to the global semiconductor and related industries.
Mr. McGillicuddy was as a partner with KPMG LLP from 1975 until his retirement in 2000. During his tenure with KPMG, he served as an Audit Partner, SEC Reviewing Partner, Partner-in-Charge of Professional Practice, and in various management positions. He is a former chairman of the Better Business Bureau of Massachusetts. He holds a Professional Director Certification from the American College of Corporate Directors.
Ellen Zane, Board Member
Ellen Zane is a nationally renowned health care leader who recently retired as President and Chief Executive Officers of Tufts Medical Center and the Floating Hospital for Children. She was the first woman to run the hospital in its 218-year history. Ms. Zane remains involved at Tufts Medical Center as a vice chair of the Board of Trustees.
Ms. Zane is currently a Director of Brooks Automation (NASDAQ-BRKS); a Director of Haemonetics Corporation (NYSE-HAE); and a Director of Parexel International (NASDAQ-PRXL). She is a Director of Press Ganey, a private company nationally known as the preeminent provider of patient satisfaction measurement and data in acute hospital settings; and a Trustee of the George Washing University, Washington, D.C.
Amy Rojik, Partner, BDO USA, LLP
Amy Rojik has spent 11 years with BDO as part of our National Assurance practice directing, developing, and delivering technical accounting and auditing learning initiatives for staff through partners. She helped establish and currently directs the firm’s external Corporate Governance and Financial Reporting Center. She is responsible for a variety of educational programming and thought leadership publications and practice aids related to corporate governance, in particular audit committees, cybersecurity, fraud, and succession planning.
Prior to joining BDO, Ms. Rojik has a combined 11 years of largest firm public accounting experience serving manufacturing and high technology companies.